Sign inJoin waitlistJoin the waitlist

JO

Julie Olsson

Pulmonary Disease

Credentials: ·

Research

Efficacy and safety of lebrikizumab in patients with uncontrolled asthma (LAVOLTA I and LAVOLTA II): replicate, phase 3, randomised, double-blind, placebo-controlled trials
The Lancet Respiratory Medicine · 2016 · 364 citations
Lebrikizumab in moderate-to-severe asthma: pooled data from two randomised placebo-controlled studies
Thorax · 2015 · 315 citations
Future directions in idiopathic pulmonary fibrosis research. An NHLBI workshop report
American Journal of Respiratory and Critical Care Medicine · 2014 · 207 citations

Michael Gould
3 papers
Nicola Hanania
3 papers
RD
Ramona Doyle
3 papers
PK
Phillip Korenblat
2 papers
Alan Skarbnik
1 paper
AT
Andrew Tager
1 paper
BH
Bradley Hunter
1 paper · 1 as a fellow
Christine Garcia
1 paper
Clay Marsh
1 paper
Craig Henke
1 paper
DM
Dana McClintock
1 paper
David Schwartz
1 paper